EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

COMBINATION OF EUDRAGIT RL 100 AND LACTOSE IN A MATRIX-BASED SUSTAINED-RELEASE THEOPHYLLINE TABLET SYSTEM

Fransiska Dua Lair, Endang Diyah Ikasari, Intan Martha Cahyani

Medical Sains : Jurnal Ilmiah Kefarmasian · 16.06.2026 · 11 (2) · 213-222

DOI: 10.37874/ms.v11i2.1959 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sains : Jurnal Ilmiah Kefarmasian, online erschienen am 16.06.2026. Verfasst von Fransiska Dua Lair und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of sustained-release theophylline preparations is crucial for suppressing plasma level fluctuations and improving safety, given the drug's short half-life and narrow therapeutic index. This study focused on designing sustained-release matrix tablets using a combination of Eudragit RL 100 and lactose and evaluating their effects on granule characteristics, tablet physical quality, and drug release profile. The evaluation showed that all granules had good flow properties, with a rate of more than 10 g/s. Physical evaluation of the preparation showed that F2 and F3 met the hardness and friability standards, whereas F1 did not meet the criteria. Dissolution tests indicated that F2 and F3 met the USP requirements for sustained-release theophylline preparations at 2, 4, and 6 hours. Release kinetics analysis confirmed that the matrix tablets followed the Korsmeyer-Peppas and Higuchi patterns, indicating a dominant release mechanism via diffusion within the polymer matrix. Based on the overall results, formula F2 provided the best release profile and physical quality and can therefore be considered as a primary candidate for sustained-release theophylline tablet formulation. Keywords: Theophylline; Sustained release tablets; Matrix systems; Dissolution; Release kinetics

Zitieren

APA

Lair, F. D., Ikasari, E. D., & Cahyani, I. M. (2026). COMBINATION OF EUDRAGIT RL 100 AND LACTOSE IN A MATRIX-BASED SUSTAINED-RELEASE THEOPHYLLINE TABLET SYSTEM. Medical Sains : Jurnal Ilmiah Kefarmasian, 11(2), 213-222. https://doi.org/10.37874/ms.v11i2.1959

Vancouver

Lair FD, Ikasari ED, Cahyani IM. COMBINATION OF EUDRAGIT RL 100 AND LACTOSE IN A MATRIX-BASED SUSTAINED-RELEASE THEOPHYLLINE TABLET SYSTEM. Medical Sains : Jurnal Ilmiah Kefarmasian. 2026;11(2):213-222. doi:10.37874/ms.v11i2.1959

BibTeX
@article{Lair2026,
  author = {Lair, Fransiska Dua and Ikasari, Endang Diyah and Cahyani, Intan Martha},
  title = {COMBINATION OF EUDRAGIT RL 100 AND LACTOSE IN A MATRIX-BASED SUSTAINED-RELEASE THEOPHYLLINE TABLET SYSTEM},
  journal = {Medical Sains : Jurnal Ilmiah Kefarmasian},
  year = {2026},
  volume = {11},
  number = {2},
  pages = {213--222},
  doi = {10.37874/ms.v11i2.1959}
}
Kostenlos starten →